cover image: The Xylazine Scourge Widens

20.500.12592/5xu47qi

The Xylazine Scourge Widens

17 Jul 2024

Millennium Health, a drug testing company that monitors drug use for pain management and drug addiction treatment centers, publishes "Signals Reports" on emerging drug use trends based on urine drug test samples across the country. In September 2023, the Millenium Signals Report revealed their labs detected the veterinary tranquilizer xylazine, which drug trafficking organizations mix with fentanyl to enhance its potency (users call it "tranq"), in all regions of the country but most heavily concentrated in the eastern US. The report found that people who tested positive for fentanyl plus xylazine were more likely to use multiple other substances as well, including cocaine, methamphetamine, heroin, and diverted prescription pain pills. On July 16, Millenium Health published a "Signals Alert" warning that the xylazine scourge has picked up steam in western states. The report states that since the White House Office of National Drug Control Policy (ONDCP) declared xylazine an emerging threat in April 2023, "the greatest gains in xylazine use were largely in the western half of the US; the Pacific, Mountain, and West North Central Census Divisions all increased significantly; New England also increased significantly."
trade policy education banking and finance regulation criminal justice monetary policy constitutional law immigration public opinion health care drug war tax and budget policy government and politics technology and privacy free speech and civil liberties poverty and social welfare global freedom defense and foreign policy

Authors

Jeffrey A. Singer

Pages
3
Published in
United States of America

Table of Contents

Related Topics

All